•  

     

    NEWS

    The most relevant news about our Group, in Argentina and around the world.

CHEMO awarded the “Tejiendo Sueños de Economía Social” prize by ASPRONA-León

 

CHEMO pharmaceutical group’s twofold commitment to improving global health and contributing positively to the local communities where it conducts its business activities has been recognised with an award. The group’s León Farma facility has been commended as a model example for the social integration of people with intellectual disabilities.

The León Farma plant has been working for five years with ASPRONA-León, a not-for-profit organisation that has strong ties to the province and is dedicated to helping and integrating people with disabilities.

Among other projects, the association works with León Farma to carry out certain manual tasks associated with processed/packaged products, and also manages the workwear laundry and gardening at the facility.

To commemorate this close working relationship, and coinciding with the organisation’s 50th anniversary, ASPRONA-León voted unanimously to award León Farma with the “Tejiendo Sueños de Economía Social” (Building Towards a Social Economy) award for the “sensitivity and support” shown in its inclusive approach towards people with intellectual disabilities, and for “setting the standard” for businesses in the province of Léon.

The award was presented at a gala event attended by various officials, including local mayor, Emilio Gutiérrez, and the Family and Equal Opportunities minister for Castile-León, Milagros Marcos, who singled out the facility as an example for other business to follow.

 

Top Story

News

Algunas aclaraciones sobre la vacuna | Hugo Sigman

Por Hugo Sigman En momentos en que la segunda ola de Covid se cobra más y más muertos, con muchas familias perdiendo a sus seres queridos y el sistema de salud muy estresado, la intoxicación de noticias falsas sólo contribuye … Continue reading

+

Latest News

News Mabxience

Hugo Sigman, sobre la vacuna de AstraZeneca: “Confiamos en que las pruebas serán exitosas”

+

News Grupo Insud Mundo Sano

El futuro de la pandemia visto por la bioquímica Silvia Gold: “Mucho de lo que aprendimos con dengue, creemos que es lo que hay que hacer con COVID-19″

+

News Grupo Insud

Hugo Sigman: “El único negocio que tengo con el Estado representa el 1,5% de mi facturación”

+

News Top Story Grupo Insud

Silvia Gold: “Las vacunas que más esperanza nos generan son las de vector viral”

+

News Top Story Mabxience

mAbxience: cómo es el laboratorio argentino que va a producir la vacuna de la Universidad de Oxford y AstraZeneca para América Latina

+

News Inmunova Top Story

ANMAT aprobó estudio clínico en humanos para el suero anti-Covid-19

+

News Grupo Insud

Startups con participación del CONICET se presentarán en BioArgentina 2021

+

News Grupo Insud

La OPS selecciona centros en Argentina y Brasil para desarrollar vacunas de ARNm contra la COVID-19

+